The essential cofactor of the enzyme ribonucleotide reductase is a stable tyrosyl free radical adjacent to a carboxylate- and oxide- bridged diiron(III) cluster. This cofactor is the target of existing anticancer and antiviral drugs and is an attractive target for design of new pharmaceuticals. The cofactor can assemble spontaneously into the enzymes from Escherichia coli and mammals when they are exposed to Fe(II) ions and molecular oxygen. The assembly reaction comprises binding of Fe(II) ions by the protein and subsequent reaction of its diiron(II) cluster with O2 to form the tyrosyl radical and diiron(III) cluster. The oxygen binding/tyrosyl radical formation phase of the reaction is quite complex and poorly understood. The reaction has similarities to the catalytic reactions of structurally-related proteins such as methane monooxygenase and stearoyl acyl carrier protein delta desaturase. Many believe that similar intermediate diiron structures form in each of these reactions. If so, each protein must interact with the common diiron intermediate(s) to guide the reaction down the appropriate mechanistic pathway to the desired outcome. In no case have the details of these interactions been fully discovered. We have constructed a series of engineered ribonucleotide reductase proteins that interact with different diiron intermediates formed in their reactions with O2 in very distinct and interesting ways. The mechanistic characterization of the O2 reactions of these proteins and the structural characterization of their diiron intermediates that we propose to undertake should indicate which particular features of the natural ribonucleotide reductase protein are important for it to ensure the desired reaction outcome in preference to those that occur in the other diiron proteins. Understanding this control should suggest vulnerabilities that might be exploited for drug design. In addition, the characterization of engineered proteins that do carry out other reactions should prove instructive in the design of synthetic diiron clusters that can also mediate the interesting and important oxidation reactions carried out by members of this grown class of proteins.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM055365-07
Application #
6627209
Study Section
Metallobiochemistry Study Section (BMT)
Program Officer
Carter, Anthony D
Project Start
1997-01-01
Project End
2004-12-31
Budget Start
2003-01-01
Budget End
2003-12-31
Support Year
7
Fiscal Year
2003
Total Cost
$217,044
Indirect Cost
Name
Pennsylvania State University
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
003403953
City
University Park
State
PA
Country
United States
Zip Code
16802
Martinie, Ryan J; Blaesi, Elizabeth J; Krebs, Carsten et al. (2017) Evidence for a Di-?-oxo Diamond Core in the Mn(IV)/Fe(IV) Activation Intermediate of Ribonucleotide Reductase from Chlamydia trachomatis. J Am Chem Soc 139:1950-1957
Livada, Jovan; Martinie, Ryan J; Dassama, Laura M K et al. (2015) Direct Measurement of the Radical Translocation Distance in the Class I Ribonucleotide Reductase from Chlamydia trachomatis. J Phys Chem B 119:13777-84
Krebs, Carsten; Dassama, Laura M K; Matthews, Megan L et al. (2013) Novel Approaches for the Accumulation of Oxygenated Intermediates to Multi-Millimolar Concentrations. Coord Chem Rev 257:
Worsdorfer, Bigna; Conner, Denise A; Yokoyama, Kenichi et al. (2013) Function of the diiron cluster of Escherichia coli class Ia ribonucleotide reductase in proton-coupled electron transfer. J Am Chem Soc 135:8585-93
Kwak, Yeonju; Jiang, Wei; Dassama, Laura M K et al. (2013) Geometric and electronic structure of the Mn(IV)Fe(III) cofactor in class Ic ribonucleotide reductase: correlation to the class Ia binuclear non-heme iron enzyme. J Am Chem Soc 135:17573-84
Dassama, Laura M K; Krebs, Carsten; Bollinger Jr, J Martin et al. (2013) Structural basis for assembly of the Mn(IV)/Fe(III) cofactor in the class Ic ribonucleotide reductase from Chlamydia trachomatis. Biochemistry 52:6424-36
Dassama, Laura M K; Silakov, Alexey; Krest, Courtney M et al. (2013) A 2.8 A Fe-Fe separation in the Fe2(III/IV) intermediate, X, from Escherichia coli ribonucleotide reductase. J Am Chem Soc 135:16758-61
Pandelia, Maria E; Li, Ning; Nørgaard, Hanne et al. (2013) Substrate-triggered addition of dioxygen to the diferrous cofactor of aldehyde-deformylating oxygenase to form a diferric-peroxide intermediate. J Am Chem Soc 135:15801-12
Dassama, Laura M K; Yosca, Timothy H; Conner, Denise A et al. (2012) O(2)-evolving chlorite dismutase as a tool for studying O(2)-utilizing enzymes. Biochemistry 51:1607-16
Dassama, Laura M K; Boal, Amie K; Krebs, Carsten et al. (2012) Evidence that the ? subunit of Chlamydia trachomatis ribonucleotide reductase is active with the manganese ion of its manganese(IV)/iron(III) cofactor in site 1. J Am Chem Soc 134:2520-3

Showing the most recent 10 out of 18 publications